Ignite Creation Date:
2025-12-26 @ 10:58 AM
Ignite Modification Date:
2025-12-29 @ 1:41 PM
Study NCT ID:
NCT06993506
Status:
NOT_YET_RECRUITING
Last Update Posted:
2025-05-29
First Post:
2025-05-12
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Real-world Study of SKB264 Monotherapy or Combination Therapy in Recurrent or Metastatic HER2-negative Breast Cancer
Sponsor:
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2025-08-01
Start Date Type:
ESTIMATED
Primary Completion Date:
2027-08-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2027-10-31
Completion Date Type:
ESTIMATED
First Submit Date:
2025-05-12
First Submit QC Date:
None
Study First Post Date:
2025-05-29
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-05-20
Last Update Post Date:
2025-05-29
Last Update Post Date Type:
ACTUAL